Early research (Phase 1)Study completedNCT03475251What this trial is testingCS1003 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Cancer CStone Pharmaceuticals 108
Testing effectiveness (Phase 2)UnknownNCT04368273What this trial is testingPd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer.Who this might be right forCervical Cancer Peking University Third Hospital 30
Not applicableActive Not RecruitingNCT06688786What this trial is testingA Pospective, Single-arm, Multicenter Clinical Trial Evaluating Preoperative Neoadjuvant mFOLFOX6 Chemotherapy in Combination With PD1 Monoclonal Antibody in MSS/pMMR Locally Advanced Rectal CancerWho this might be right forLocally Advanced Rectal Cancer (LARC) Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05996523What this trial is testingPhase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal CancerWho this might be right forOropharyngeal Squamous Cell Carcinoma (SCC) National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)UnknownNCT03972722What this trial is testingStudy of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical CancerWho this might be right forCervical Cancer Guangzhou Gloria Biosciences Co., Ltd. 89
Large-scale testing (Phase 3)Looking for participantsNCT07822646What this trial is testingManganese-primed Immunochemotherapy in Patients With Advanced Ovarian CancerWho this might be right forOvarian Cancer Chinese PLA General Hospital 120
Testing effectiveness (Phase 2)UnknownNCT03811379What this trial is testingToripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed ChemotherapyWho this might be right forSmall Cell Carcinoma of EsophagusAdvanced Cancer Sun Yat-sen University 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT03743662What this trial is testingNivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated GlioblastomaWho this might be right forGlioblastoma Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT05426005What this trial is testingCadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal CancerWho this might be right forColorectal Cancer Stage IVMismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H) Sun Yat-sen University 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05787613What this trial is testingA Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC PatientsWho this might be right forNSCLC Stage IV Shanghai Henlius Biotech 132
Testing effectiveness (Phase 2)Study completedNCT03767582What this trial is testingTrial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.Who this might be right forLocally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06856278What this trial is testingClinical Study of NKG2D CAR-NK Combined with PD-1 Monoclonal Antibody in the Treatment of ATCWho this might be right forAnaplastic Throid Carcinoma Zhejiang Provincial People's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07150949What this trial is testingLong-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)Who this might be right forLocally Advanced Rectal CancerNeoadjuvant Therapy Fudan University 138
Not applicableUnknownNCT05349045What this trial is testingAngiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal CancerWho this might be right forEsophageal Neoplasms The First Affiliated Hospital of Zhengzhou University 300
Testing effectiveness (Phase 2)Looking for participantsNCT07127822What this trial is testingAssessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric CancerWho this might be right forGastric / Gastroesophageal Junction AdenocarcinomaMSI-H Cancer Peking University 106
Testing effectiveness (Phase 2)Looking for participantsNCT06587802What this trial is testingPhase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical CarcinomaWho this might be right forAdrenocortical Carcinoma Sun Yat-sen University 18
Early research (Phase 1)Study completedNCT02936752What this trial is testingTesting the Safety and Efficacy of the Combination of the Antibody Pembrolizumab and Entinostat in Patients With Myelodysplastic Syndrome Who Are Not Responding to Hypomethylating AgentsWho this might be right forMyelodysplastic Syndrome National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Looking for participantsNCT06642792What this trial is testingAK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin LymphomaWho this might be right forClassic Hodgkin Lymphoma Akeso 280
Testing effectiveness (Phase 2)UnknownNCT05723432What this trial is testingKD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced MelanomaWho this might be right forMelanoma Shanghai Kanda Biotechnology Co., Ltd. 84
Testing effectiveness (Phase 2)Looking for participantsNCT05033392What this trial is testingPD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction CancerWho this might be right forStomach Neoplasms Wan He 62